Coming up on today's show.

About 15% of our population dies of Alzheimer's.

So about 45 million of the currently living Americans will die of Alzheimer's.

We can reduce that number dramatically.

You don't have to wait for significant decline.

We've just finished a randomized clinical trial with the most striking

reversals that have ever been reported. If you look at their memory scores, the group that is

getting standard of care is going down, down, down, the group that is on the precision medicine

approach is going up, up, up in their cognitive scores. The impact of the treatment was greater

than any published trial,

seven times of the one of the quote, breakthrough drugs and four times of the other breakthrough

drug. We were never taught that, hey, a common contributor to cognitive decline is mycotoxins.

Probably number one is metabolic dysfunction. You multiply your risk by about threefold.

The armamentarium that we have to use for optimizing cognition is huge. All these things are

available finding the right thing for the right person with the right test. That's the trick.

People have said over the years, oh, nothing can reverse cognitive decline. No, we're documenting it daily now.

Dr. Bredesen, at this point, you say Alzheimer's disease is now an optional life experience.

Explain what you mean by this. Yeah, because there have been so many

advances over the last decade. So for example, we now know that you can look at blood values,

P-Tow 217, GFAP, NFL, NFLament light, A-Beta-4242-40 ratio.

So just as hemoglobin A1C came on the scene about 50, 55 years ago, and people could see,

I have pre-diabetes, I don't have to wait to have diabetes and have visual loss and things like that.

...